Contact and Collaboration
PET radiopharmacy is a University Hospital facility who has a close links with pharmaceutical companies widen our scientific portfolio by facilitating new research strategies and providing access to novel drugs and instruments. Contractual imaging research is based on joint publications or, if confidentially is required, to financial support providing a greater flexibility to support clinical diagnosis and laboratory infrastructure.
Our main focus is to bring newly developed PET radiopharmaceuticals to the patient. Translational research is intended to further provide clinics with highly specific and selective biomarkers, enabling the visualization of new relevant target structures and mechanisms, thereby reinforcing the applicability of PET diagnostics for the benefit of patients.
We invite you to contact us and/or come and visit our site to learn more about our production and R&D-pipeline and the fascinating options that our platform could offer for clinical and preclinical collaboration.
|Head of Diagnostic imaging center |
Hanna Mussalo, MD, Docent
+358 44 711 3279
|For research & industry collaboration |
Tracers and preclinical collaboration
Pekka Poutiainen, PhD
+358 44 717 2007